Drug profile · INN
adalimumab-aaty
YUFLYMA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
adalimumab-aaty (YUFLYMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN adalimumab-aaty
Brand YUFLYMA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is adalimumab-aaty?
adalimumab-aaty (YUFLYMA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for adalimumab-aaty?
YUFLYMA is a marketed brand name for adalimumab-aaty. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of adalimumab-aaty?
adalimumab-aaty has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.